scholarly journals COVID-19 in Continental Europe

2021 ◽  
Vol 9 (2) ◽  
Author(s):  
Leila Moradi
Keyword(s):  
Disease Transmission ◽  
Ecological Study ◽  
Case Fatality ◽  
World Health ◽  
Effective Vaccine ◽  
The United Kingdom ◽  
The World ◽  
Deadly Disease ◽  
Spss Software ◽  
Health Organization

Background: COVID-19 is an emerging disease that was first identified in China and then spread to most countries around the world. The disease was caused by the coronavirus and led to restrictions in most parts of the world. Definitive causes have been identified, and mortality from the disease is high in continental Europe. Objectives: This study aims to investigate the epidemiology of COVID-19 in continental Europe. Methods: This was an ecological study and described the characteristics of COVID-19 in continental Europe. Data related to the definite cases of diagnosis and death due to this disease and World Health Organization reports were recruited and transferred to Excel and SPSS software. Case fatality rates were also calculated for each country. Results: The highest confirmed number of diagnosed cases of COVID-19 was in Russia with 4,333,029 cases, and the highest number of deaths reported due to COVID19 was in the United Kingdom with 124,419 cases. The highest case fatality rates were from Bulgaria 4.08%. Conclusions: COVID-19 is a highly contagious and deadly disease, and until an effective vaccine is available, the prevention of disease transmission is possible only through observing social distancing.

scholarly journals COVID-19 in Southeast Asia

2021 ◽  
Vol In Press (In Press) ◽  
Author(s):  
Leila Moradi
Keyword(s):  
Southeast Asia ◽  
Ecological Study ◽  
Case Fatality ◽  
World Health ◽  
Laboratory Equipment ◽  
Epidemiological Features ◽  
The World ◽  
Other Information ◽  
Spss Software ◽  
Health Organization

Background: The emerging disease COVID-19 was first identified in China in late 2019. It soon spread to most countries and continents. The symptoms of this disease range from asymptomatic to severe and fatal. This disease is now an important pandemic and has created an emergency in the world. Objectives: This study aimed to investigate the epidemiology of COVID-19 in Southeast Asia. Methods: This ecological study describes the epidemiological features of COVID-19 in southeastern Asia. Data related to identified definite cases and deaths due to this disease along with other information were extracted from the reports of the World Health Organization and imported to SPSS software. The case fatality rate was calculated separately for each country. Results: The highest number of reported cases of this disease was 30,458,251 in India, and the highest number of death was in this country with 400,312 cases, and the highest mortality rate was in Indonesia with 2.67%. Conclusions: Using masks and observing social distance and quarantine rules, as well as upgrading diagnostic and laboratory equipment to identify patients, are effective ways to prevent COVID-19 transmission.

scholarly journals Severe Acute Respiratory Syndrome: international update

2003 ◽  
Vol 7 (14) ◽  
Author(s):  
P Horby ◽  
A Nicoll
Keyword(s):  
Hong Kong ◽  
Severe Acute Respiratory Syndrome ◽  
Case Fatality ◽  
Guangdong Province ◽  
World Health ◽  
The United Kingdom ◽  
Current Transmission ◽  
The World ◽  
Health Organization ◽  
Local Transmission

As of 2 April 2003, 2223 cases of Severe Acute Respiratory Syndrome (SARS) and 78 deaths have been reported to the World Health Organization (WHO), a case fatality rate of 3.5% (http://www.who.int/csr/sarscountry/2003_04_02/en/). This is an increase of four to fivefold in the global totals in the last seven days (http://www.who.int/csr/sarscountry/2003_03_25/en/) with the greatest proportionate and absolute increases being in China (Hong Kong and Guangdong Province), and to a much lesser extent in Canada. There has been little absolute rise in other country totals. Eighteen countries have now reported cases but in most of these no transmission seems to have occurred. Local transmission has occurred in Hanoi (Vietnam), Singapore, Toronto (Canada), Taiwan, and the following parts of China: Guangdong Province; Beijing; Shanxi; and the special administrative region of Hong Kong. In the United Kingdom three probable SARS cases have been reported; all have now recovered. Indeed, the only areas where WHO feels there is evidence consistent with current transmission are Hong Kong and Guangdong (http://www.who.int/csr/sarsarchive/2003_02_02b/en/), and the WHO has issued advice to international travellers not to travel to or through either area.

scholarly journals COVID-19 Pandemic in the World and its Relation to Human Development Index: A Global Study

2020 ◽  
Vol 15 (5) ◽  
Author(s):  
Zaher Khazaei ◽  
Elaheh Mazaheri ◽  
Ali Hasanpour-Dehkordi ◽  
Sajjad Rahimi Pordanjani ◽  
Ahmad Naghibzadeh-Tahami ◽  
...  
Keyword(s):  
Human Development ◽  
Human Development Index ◽  
Ecological Study ◽  
Large Family ◽  
The United States ◽  
World Health ◽  
Development Index ◽  
The United Kingdom ◽  
The World ◽  
Health Organization

: Coronaviruses are a large family and a subset of Coronaviridae that include common cold viruses and other severe diseases like severe acute respiratory syndrome (SARS-CoV), Middle East respiratory syndrome (MERS-CoV), and coronavirus disease 2019 (COVID-19). This is an ecological study based on statistics of the prevalence of coronavirus disease until 30 April 2020, based on the reports sent to the World Health Organization (WHO). This study investigates the distribution of the incidence and trend of the incidence rate of COVID-19 in countries, and its relation with the human development index (HDI) until 30 April 2020. The results showed that the most cases of coronavirus disease until the mentioned date were in the United States of America (1,003,947 cases), Spain (212,917 cases), Italy (203,591 cases), the United Kingdom (165,225 cases), and Germany (159,119 cases), in sequence. The results exhibited a significant positive correlation between the incidence of COVID-2019 and HDI in the world (r = 0.470, P < 0.0001).

Critical Insight into the Attributes of Emerging Novel Coronavirus (COVID-19) in India and Across the World

Coronaviruses ◽  
2020 ◽  
Vol 1 (1) ◽  
pp. 49-56
Author(s):  
Gaurav M. Doshi ◽  
Hemen S. Ved ◽  
Ami P. Thakkar
Keyword(s):  
Review Article ◽  
World Health ◽  
Effective Vaccine ◽  
Human Contact ◽  
The World ◽  
Critical Insight ◽  
Novel Coronavirus ◽  
Health Organization ◽  
Insight Into ◽  
Old Drugs

The World Health Organization (WHO) has recently announced the spread of novel coronavirus (nCoV) globally and has declared it a pandemic. The probable source of transmission of the virus, which is from animal to human and human to human contact, has been established. As per the statistics reported by the WHO on 11th April 2020, data has shown that more than sixteen lakh confirmed cases have been identified globally. The reported cases related to nCoV in India have been rising substantially. The review article discusses the characteristics of nCoV in detail with the probability of potentially effective old drugs that may inhibit the virus. The research may further emphasize and draw the attention of the world towards the development of an effective vaccine as well as alternative therapies. Moreover, the article will help to bridge the gap between the new researchers since it’s the current thrust area of research.

scholarly journals Pharmacotherapeutic management of chronic viral hepatitis

2021 ◽  
Vol 2 (4) ◽  
pp. 1-8
Author(s):  
Gabriela Mitea ◽  
Marius Daniel Radu ◽  
Ana Maria Ionescu ◽  
Nicoleta Blebea
Keyword(s):  
Hepatitis B ◽  
Viral Hepatitis ◽  
World Health Organization ◽  
Geographical Area ◽  
Chronic Viral Hepatitis ◽  
World Health ◽  
Effective Vaccine ◽  
Special Importance ◽  
The World ◽  
Health Organization

In infectious diseases, viral hepatitis has an increased incidence, being an important cause of morbidity and mortality, being a "sentinel" indicator of the socio-economic and hygienic-cultural standard of a geographical area. The World Health Organization (WHO) admits the following types of hepatitis viruses: A, B, B + D, C, E, F and G. Among the viral entities recognized by the WHO, a special importance in terms of incidence, evolution over time with the risk of chronicity and the therapeutic options are presented by hepatitis B and C. There is currently an effective vaccine as well as treatment for hepatitis B. There is no vaccine for hepatitis C, but in recent years considerable progress has been made in treating this disease. Also, the introduction of drugs known as direct-acting antivirals makes it possible to cure over 90% of patients within 2-3 months. But in many countries, current drug policies, regulations and prices keep treatment out of the reach of most people with hepatitis. Eradication of viral hepatitis is possible if greater emphasis is placed on prevention, diagnosis and treatment. Vaccination is very important, as it is possible for types A and B of hepatitis. Early diagnosis is also extremely important, given that there are currently very effective drugs that can prevent the development of liver cancer. The WHO also noted that about two million people worldwide become ill each year due to the reuse of syringes and stressed the importance of checking blood donors to see if they are not carriers of hepatitis B or C viruses. Therefore, the purpose of this article is to highlight the pharmacological treatment and the main therapeutic and prevention schemes currently used for patients with these liver diseases. The paper was based on the most popular methods of identification of the latest international information about the treatment of hepatitis (by electronic search using Pubmed, SciFinder, Scirus, GoogleScholar and Web of Science). We also consulted the global literature cited in the hepatitis database of the World Health Organization (WHO) updated frequent from the current literature on this topic.

scholarly journals Clinical Considerations in Otorhinolaryngology Practice in COVID-19 Pandemic Era

2021 ◽  
Vol 64 (5) ◽  
pp. 297-303
Author(s):  
Soo Ah Son ◽  
Se Hwan Hwang
Keyword(s):  
Disease Transmission ◽  
Direct Contact ◽  
Clinical Characteristics ◽  
World Health ◽  
Outpatient Clinics ◽  
Protective Equipment ◽  
Upper Aerodigestive Tract ◽  
The World ◽  
Clinical Considerations ◽  
Health Organization

The coronavirus disease 2019 (COVID-19) epidemic originated in Wuhan, China and spread rapidly worldwide, leading the World Health Organization to declare an official global COVID- 19 pandemic in March 2020. The upper aero-digestive tract is known to be the highest viral load reside. The infection spreads via droplets or direct contact with contaminated surfaces via aeorsol. The otolaryngologists deal with diseases of the upper-aerodigestive tract and routinely are engaged in respiratory droplet and aerosol-generating procedures (AGP). In particular, because airborne transmission occurs during examination and AGP, otolaryngologists are considered to be at a high risk of contracting COVID-19 during this pandemic. Therefore otolaryngologists need to do precautions to protect staff and patients and minimize transmission of the disease. We also need to wear adequate personal protective equipment according to the examination and procedure. This article discusses the disease transmission and clinical characteristics of COVID-19 as well as precaution guidelines in outpatient clinics of otorhinolaryngology.

scholarly journals Fighting Strategies Against the Novel Coronavirus Pandemic: Impact on Global Economy

2020 ◽  
Vol 8 ◽  
Author(s):  
Bapi Gorain ◽  
Hira Choudhury ◽  
Nagashekhara Molugulu ◽  
Rajani B. Athawale ◽  
Prashant Kesharwani
Keyword(s):  
Disease Transmission ◽  
Global Economy ◽  
World Health ◽  
World Population ◽  
Mortality And Morbidity ◽  
Short Period ◽  
The World ◽  
Treatment Measures ◽  
Novel Coronavirus ◽  
Health Organization

Sudden outbreak of a new pathogen in numbers of pneumonic patients in Wuhan province during December 2019 has threatened the world population within a short period of its occurrence. This respiratory tract–isolated pathogen was initially named as novel coronavirus 2019 (nCoV-2019), but later termed as SARS-CoV-2. The rapid spreading of this infectious disease received the label of pandemic by the World Health Organization within 4 months of its occurrence, which still seeks continuous attention of the researchers to prevent the spread and for cure of the infected patients. The propagation of the disease has been recorded in 215 countries, with more than 25.5 million cases and a death toll of more than 0.85 million. Several measures are taken to control the disease transmission, and researchers are actively engaged in finding suitable therapeutics to effectively control the disease to minimize the mortality and morbidity rates. Several existing potential candidates were explored in the prevention and treatment of worsening condition of COVID-19 patients; however, none of the formulation has been approved for the treatment but used under medical supervision. In this article, a focus has been made to highlight on current epidemiology on the COVID-19 infection, clinical features, diagnosis, and transmission, with special emphasis on treatment measures of the disease at different stages of clinical research and the global economic influence due to this pandemic situation. Progress in the development on vaccine against COVID-19 has also been explored as important measures to immunize people. Moreover, this article is expected to provide information to the researchers, who are constantly combating in the management against this outbreak.

scholarly journals A comparison of COVID-19, SARS and MERS

PeerJ ◽  
2020 ◽  
Vol 8 ◽  
pp. e9725 ◽  
Author(s):  
Tingting Hu ◽  
Ying Liu ◽  
Mingyi Zhao ◽  
Quan Zhuang ◽  
Linyong Xu ◽  
...  
Keyword(s):  
Severe Acute Respiratory Syndrome ◽  
Case Fatality ◽  
Hubei Province ◽  
World Health ◽  
Atypical Pneumonia ◽  
Organization Studies ◽  
Optimal Method ◽  
The World ◽  
Novel Coronavirus ◽  
Health Organization

In mid-December 2019, a novel atypical pneumonia broke out in Wuhan, Hubei Province, China and was caused by a newly identified coronavirus, initially termed 2019 Novel Coronavirus and subsequently severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As of 19 May 2020, a total of 4,731,458 individuals were reported as infected with SARS-CoV-2 among 213 countries, areas or territories with recorded cases, and the overall case-fatality rate was 6.6% (316,169 deaths among 4,731,458 recorded cases), according to the World Health Organization. Studies have shown that SARS-CoV-2 is notably similar to (severe acute respiratory syndrome coronavirus) SARS-CoV that emerged in 2002–2003 and Middle East respiratory syndrome coronavirus (MERS-CoV) that spread during 2012, and these viruses all contributed to global pandemics. The ability of SARS-CoV-2 to rapidly spread a pneumonia-like disease from Hubei Province, China, throughout the world has provoked widespread concern. The main symptoms of coronavirus disease 2019 (COVID-19) include fever, cough, myalgia, fatigue and lower respiratory signs. At present, nucleic acid tests are widely recommended as the optimal method for detecting SARS-CoV-2. However, obstacles remain, including the global shortage of testing kits and the presentation of false negatives. Experts suggest that almost everyone in China is susceptible to SARS-CoV-2 infection, and to date, there are no effective treatments. In light of the references published, this review demonstrates the biological features, spread, diagnosis and treatment of SARS-CoV-2 as a whole and aims to analyse the similarities and differences among SARS-CoV-2, SARS-CoV and MERS-CoV to provide new ideas and suggestions for prevention, diagnosis and clinical treatment.

scholarly journals COVID-19, Australia: Epidemiology Report 14 (Reporting week to 23:59 AEST 3 May 2020)

2020 ◽  
Vol 44 ◽  
Author(s):  
Keyword(s):  
United States Of America ◽  
Case Fatality ◽  
The United States ◽  
International Travel ◽  
World Health ◽  
Public Health Action ◽  
The United Kingdom ◽  
The World ◽  
Overseas Travel ◽  
Health Action

Confirmed cases in Australia notified up to 03 May 2020: notifications = 6,784; deaths = 89. The reduction in international travel and domestic movement, social distancing measures and public health action have likely slowed the spread of COVID-19 in Australia. Currently new notifications in Australia are mostly considered to be locally-acquired with some cases still reported among people with recent overseas travel. Most locally-acquired cases can be linked back to a confirmed case or known cluster, with a small portion unable to be epidemiologically linked to another case. The ratio of overseas-acquired cases to locally-acquired cases varies by jurisdiction. The crude case fatality rate (CFR) in Australia remains low (1.3%) compared to the World Health Organization’s globally-reported rate (7.1%) and to other comparable high-income countries such as the United States of America (5.7%) and the United Kingdom (15.4%). The lower CFR in Australia is likely reflective of high case ascertainment including detection of mild cases. Internationally, cases continue to increase. The rates of increase have started to slow in several regions, although it is too soon to tell whether this trend will be sustained.

Face mask detection application and dataset

2021 ◽  
Vol 27 (2) ◽  
Author(s):  
Daniel Matthias ◽  
Chidozie Managwu ◽  
O. Olumide
Keyword(s):  
Disease Transmission ◽  
Face Mask ◽  
World Health ◽  
The World ◽  
The Face ◽  
Monitoring And Enforcement ◽  
Health Organization ◽  
Experimental Findings ◽  
Recognition Software ◽  
Deep Learning Model

The COVID–19 pandemic is, without any doubt, changing our world in ways that are beyond our wildest imagination. In a bid to curb the spiraling negative fallouts from the virus that has resulted in a large number of casualties and security concerns. The World Health Organization, amongst other safety protocols, recommended the compulsory wearing of face masks by individuals in public spaces. The problem with the enforcement of this and other relevant safety protocols, all over the world, is the reluctance and outright refusal of citizens to comply and the inability of relevant agencies to monitor and enforce compliance. This paper explores the development of a CCTV–enabled facial mask recognition software that will facilitate the monitoring and enforcement of this protocol. Such models can be particularly useful for security purposes in checking if the disease transmission is being kept in check. A constructive research methodology was adopted, where a pre-trained deep convolutionary neural network (CNN) (mostly eyes and forehead regions) used and the most probable limit (MPL) was use for the classification process. The designed method uses two datasets to train in order to detect key facial features and apply a decision-making algorithm. Experimental findings on the Real-World-Masked-Face-Dataset indicate high success in recognition. A proof of concept as well as a development base are provided towards reducing the spread of COVID-19 by allowing people to validate the face mask via their webcam. We recommend that the use of the app and to further investigate the development of highly robust detectors by training a deep learning model with respect to specified face-feature categories or to correctly and incorrectly wear mask categories.

Sign in / Sign up

Export Citation Format

Share Document